BioWorld - Sunday, June 7, 2026

BioWorld Science

April 20, 2022

View Archived Issues

TLR2/6 agonist AXA-042 shows antitumor activity and tolerability in vivo

Read More

Plexium compound shows the promise of BRD4 degradation for prostate cancer

Read More

Guangzhou Fermion Technology patents new CDK7 inhibitors

Read More

CSPC Zhongqi Pharmaceutical Technology divulges salts of tyrosine kinase inhibitors

Read More

Medshine Discovery identifies new CSF-1R inhibitors

Read More

New P2X3 antagonists presented by National Institute of Pharmaceutical R&D

Read More

Shanghai Visonpharma synthesizes new TLR7 agonists

Read More

Ono establishes collaborations to discover small molecules targeting GPCRs in metabolic disease

Read More

TAK-676 shows antitumor efficacy as monotherapy or in combination

Read More

MJFF grant supports Neuropore's development of TLR2 antagonist for Parkinson's disease

Read More

AUR-103 in combination with azacytidine and bortezomib for myeloma and leukemia treatment

Read More

Discovery of novel BACE1 inhibitor with optimal balance of potency and drug-like properties

Read More

Testing viruses, vaccines, to increase solid tumor CAR T persistence

Read More

Sionna closes series B financing to support development of CFTR modulators

Read More

Antengene presents anti-CLDN18.2 ATG-022 for the treatment of gastric cancer

Read More